A862 15 mg (Methylphenidate Hydrochloride Extended-Release 15 mg)
Pill with imprint A862 15 mg is Yellow & White, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release 15 mg. It is supplied by Actavis Pharma, Inc.
Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 15 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for A862 15 mg
Methylphenidate Hydrochloride Extended-Release
- Imprint
- A862 15 mg
- Strength
- 15 mg
- Color
- Yellow & White
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- CNS stimulants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Actavis Pharma, Inc.
- National Drug Code (NDC)
- 00591-3862
More about methylphenidate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (944)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- Drug class: CNS stimulants
Patient resources
- Drug Information
- Methylphenidate transdermal
- Methylphenidate Oral, Transdermal (Advanced Reading)
- Methylphenidate Transdermal (Advanced Reading)
- Methylphenidate Extended-Release Chewable Tablets
- Other brands
- Concerta, Ritalin, Ritalin LA, Quillivant XR, ... +11 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.